Chemical Works of Gedeon Richter (BUD:RICHTER) 3-Year EPS without NRI Growth Rate : 12.30% (As of Dec. 2023)

View and export this data going back to 1994. Start your Free Trial

What is Chemical Works of Gedeon Richter 3-Year EPS without NRI Growth Rate?

Chemical Works of Gedeon Richter's EPS without NRI for the three months ended in Dec. 2023 was Ft510.50.

During the past 12 months, Chemical Works of Gedeon Richter's average EPS without NRI Growth Rate was -16.80% per year. During the past 3 years, the average EPS without NRI Growth Rate was 12.30% per year. During the past 5 years, the average EPS without NRI Growth Rate was 39.50% per year. During the past 10 years, the average EPS without NRI Growth Rate was 19.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 13 years, the highest 3-Year average EPS without NRI Growth Rate of Chemical Works of Gedeon Richter was 128.10% per year. The lowest was -50.80% per year. And the median was -0.20% per year.

Competitive Comparison of Chemical Works of Gedeon Richter's 3-Year EPS without NRI Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Chemical Works of Gedeon Richter's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chemical Works of Gedeon Richter's 3-Year EPS without NRI Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Chemical Works of Gedeon Richter's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Chemical Works of Gedeon Richter's 3-Year EPS without NRI Growth Rate falls into.

Chemical Works of Gedeon Richter 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

Chemical Works of Gedeon Richter (BUD:RICHTER) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Chemical Works of Gedeon Richter 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Chemical Works of Gedeon Richter's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Chemical Works of Gedeon Richter (BUD:RICHTER) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chemical Works of Gedeon Richter PLC (BUD:RICHTER) » Definitions » 3-Year EPS without NRI Growth Rate

Comparable Companies

Traded in Other Exchanges

RGEDF:USA GEDSF:USA 0QFP:UK RIG2:Germany

Address

Gyomroi ut 19-21, Budapest, HUN, 1103

Website

https://www.richter.hu

Chemical Works of Gedeon Richter PLC is a pharmaceutical company. The company focuses on the development and manufacture of gynaecological, cardiovascular and central nervous system products. It manufactures medicines including original, generic and licenced products for treatment in the therapeutic area. The group is active in two business segments namely, the Pharmaceuticals segment comprising the research and development, manufacturing, sales and marketing of pharmaceutical products, and Wholesale and Retail segment for the products of the company. The company operates internationally and the majority of its revenue is generated from the Pharmaceuticals segment.

Chemical Works of Gedeon Richter (BUD:RICHTER) Headlines

No Headlines